Fifth Third Bancorp
PDLI

Fifth Third Bancorp’s PDL BioPharma, Inc. PDLI Stock Holding History

Fifth Third Bancorp’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,250
Closed -$4K – 2395
2016
Q3 		$4K Buy
+1,250
New +$3.97K ﹤0.01% 2035
2016
Q2 		– Sell
-110
Closed – – 2459
2016
Q1 		$0 Buy
+110
New +$343 ﹤0.01% 2947
2015
Q4 		– Sell
-5,000
Closed -$25K – 3061
2015
Q3 		$25K Sell
5,000
-7,796
-61% -$44.7K ﹤0.01% 1657
2015
Q2 		$82K Buy
+12,796
New +$85.7K ﹤0.01% 1267

Other funds holding PDLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fifth Third Bancorp's PDLI Position: Q4 2016 in Review

Fifth Third Bancorp sold out of PDL BioPharma, Inc. (PDLI) in Q4 2016, closing a stake of 1,250 shares — an estimated $4K sold.

Fifth Third Bancorp first reported a position in PDLI in Q2 2015 and held it in 4 quarters. The position peaked at $82K in Q2 2015. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

  • Fifth Third Bancorp reported no remaining PDL BioPharma, Inc. position as of Q4 2016 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,250 PDL BioPharma, Inc. shares in Q4 2016, an estimated $4K.
  • Fifth Third Bancorp first reported a position in PDL BioPharma, Inc. in Q2 2015 and held it in 4 quarters.
  • Fifth Third Bancorp's PDL BioPharma, Inc. position peaked at $82K in Q2 2015.
  • 190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on Fifth Third Bancorp's 13F filing for Q4 2016, filed 9 Feb 2017.